Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair (StAR)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective of this study is to compare the incidence of post-repair wound related complications, including hernia occurrence/recurrence, between challenging abdominal wall defects repaired with Strattice(TM) Reconstructive Tissue Matrix (TM) and those managed by standard repair. It is hypothesized that the use of Strattice(TM) TM to reinforce the repair will reduce the incidence of these post-repair complications.
| Condition | Intervention | Phase |
|---|---|---|
|
Hernia Surgical Wound Dehiscence |
Device: Strattice(TM) Reconstructive Tissue Matrix Procedure: Suture/suture with absorbable mesh |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | A Multicenter, Prospective, Single-Blind, Randomized, Controlled Study of the Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair |
- Hernia occurrence [ Time Frame: Month 12 after repair ] [ Designated as safety issue: Yes ]Hernia occurrence will be assessed by clinical evaluation. At Month 12 and at any time during the study if hernia occurrence is clinically suspected, a magnetic resonance image (MRI) will be obtained.
- Re-operation for abdominal wall repair [ Time Frame: within 12 months of repair ] [ Designated as safety issue: Yes ]need for reoperation to re-repair the original defect
- Incidence of acute complications requiring intervention (medical or surgical) [ Time Frame: First 30 days post-repair ] [ Designated as safety issue: Yes ]Incidence of complications requiring intervention (medical or surgical), including occurrence of fascial dehiscence, wound infection and seroma
| Enrollment: | 37 |
| Study Start Date: | March 2010 |
| Estimated Study Completion Date: | May 2012 |
| Estimated Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Strattice(TM) TM repair
Strattice(TM) TM will be placed in the intraperitoneal or retrorectus position to support the repair of abdominal wall defect
|
Device: Strattice(TM) Reconstructive Tissue Matrix
Strattice(TM) TM will be used to support the repair of abdominal wall defect
|
|
Active Comparator: Standard of Care repair
Abdominal wall defect will be repaired using current standard of care techniques of either suture alone or suture with absorbable surgical mesh
|
Procedure: Suture/suture with absorbable mesh
Abdominal wall defect will be repaired with suture alone or absorbable mesh with suture
|
Detailed Description:
This is a prospective, multicenter, single-blind, randomized, longitudinal, cross-over evaluation of the repair of challenging abdominal wall defects using Strattice(TM) TM or standard surgical repair. These abdominal wall defects can be acute or chronic, and include midline, transverse (including flank) as well as Pfannenstiel incisions. The skin may be closed (fascial dehiscence or incisional hernia) or open (patient with open abdomen or acute fascial dehiscence) with or without evisceration. Patients randomized to the control group who require a re-operation to perform the planned final repair or due to failure of the initial repair within 12 months, will be offered repair with Strattice™ TM (i.e. "crossed over") or if such repair not performed, the patient will have completed the study. An adaptive study design will be used to validate the initial conditional power of the study and a balanced randomization, based upon the three conditions (type of defect [dehiscence, hernia repair or open abdomen], morbidity [POSSUM score] and time since exposure of abdominal fascia/viscera) will be used to equally distribute subjects between groups.
The primary endpoint of this study is hernia occurrence at 12 months post repair and secondary endpoints include re-operation for abdominal wall repair within 12 months, incidence of complications requiring intervention(medical or surgical) within the first 30 days after repair,, length of hospitalization and resource utilization, and all cause mortality.
Subjects will be enrolled and randomized to receive Strattice(TM) TM reinforcement of repair or standard of care repair (i.e. suture alone or suture with absorbable mesh) and followed at set timepoints to observe incision site repair for surgical site events, including reoperation and hernia occurrence.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- adults (18years of age or older) who is able to provide written informed consent for study participation
- has need of surgical intervention for repair of (potentially) contaminated abdominal wall defect of >3cm and <22cm in length, where the viscera have not been exposed for more than 15 days in case of open abdomen(skin and fascia open).
- Is willing and able to return for all scheduled & required study visit.
Exclusion Criteria: at the time of randomization
- severe systemic sepsis
- frank pus in the wound, a fistula that will not be closed at the time of surgery or intra-abdominal abscess in surgical area,
- ongoing necrotizing pancreatitis,
- Is on chronic immunosuppressive therapy, or other medication that influences wound healing
- requires only short-term temporary closure,
- requires a synthetic, non-absorbable mesh to close the abdominal wall defect
- is unable to undergo general anesthesia,
- has other major organ system dysfunction or disorder that would jeopardize subject completing the 24 month study.
- Is unable to undergo an MRI scan
Contacts and Locations| France | |
| CHU Amiens Hopital Nord | |
| Amiens, France | |
| Hopital de la Pitie-Salpetriere | |
| Paris, France | |
| CHU Robert Debre | |
| Reims, France | |
| Germany | |
| Universitätsklinikum Aachen | |
| Aachen, Germany | |
| Unfallkrankenhaus Berlin | |
| Berlin, Germany | |
| St. Josef-Hospital | |
| Bochum, Germany | |
| Universitätsklinikum Düsseldorf | |
| Düsseldorf, Germany | |
| Klinikum und Fachbereich Medizin der Johann Wolfgang Goethe Universitat | |
| Frankfurt am Main, Germany | |
| Universitätsklinikum Giessen und Marburg GmbH | |
| Giessen, Germany | |
| Universitatsklinikum Hamburg-Eppendorf | |
| Hamburg, Germany | |
| Krankenhaus Agatharied GmbH | |
| Hausham, Germany | |
| Universitatsklinikum Heidelberg | |
| Heidelberg, Germany | |
| Krankenhaus Salem der Evang. Stadtmission Heidelberg | |
| Heidelberg, Germany | |
| Klinikum Konstanz | |
| Konstanz, Germany | |
| Kliniken der Stadt Köln | |
| Köln, Germany | |
| LMU Klinikum der Universität München | |
| München, Germany | |
| Technischen Universität München - Klinikum rechts der Isar | |
| München, Germany | |
| Lukaskrankenhaus | |
| Neuss, Germany | |
| Klinikum St Elisabeth Straubing GmbH | |
| Straubing, Germany | |
| Italy | |
| St Orsola-Malpighi University Hospital | |
| Bologna, Italy | |
| Netherlands | |
| Haga Ziekenhuis | |
| Den Haag, Netherlands | |
| Academisch Ziekenhuis Maastrict | |
| Maastricht, Netherlands | |
| Erasmus Medisch Centrum | |
| Rotterdam, Netherlands | |
| Spain | |
| Hospital Universitari del Mar | |
| Barcelona, Spain | |
| United Kingdom | |
| Sandwell General Hospital | |
| Birmingham, United Kingdom | |
| Raigmore Hospital | |
| Inverness, United Kingdom | |
| Manchester Royal Infirmary | |
| Manchester, United Kingdom | |
| Heart of England NHS Trust | |
| Solihull, United Kingdom | |
| Arrowe Park Hospital | |
| Upton, Wirral, United Kingdom | |
| Principal Investigator: | Angus JM Watson | Raigmore Hospital, Inverness Scotland, National Health Service, UK |
| Principal Investigator: | Berndt Reith | Klinikum Konstanz, Konstanz Germany |
| Study Chair: | Johannes Jeekel |
More Information
Publications:
| Responsible Party: | LifeCell |
| ClinicalTrials.gov Identifier: | NCT01083472 History of Changes |
| Other Study ID Numbers: | LFC2009.01.01 |
| Study First Received: | March 8, 2010 |
| Last Updated: | March 2, 2012 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices United Kingdom: National Health Service |
Keywords provided by LifeCell:
|
dehiscence laparotomy Hernia repair surgical wound surgical mesh |
Additional relevant MeSH terms:
|
Hernia Surgical Wound Dehiscence Pathological Conditions, Anatomical Postoperative Complications Pathologic Processes |
ClinicalTrials.gov processed this record on June 17, 2013